cancerworld.net valid
Automatically discovered from public files. Ownership management is optional. Inclusion does not imply endorsement or publisher participation.
Manage this listing — optional · Visit publisher ↗
Verify with your agent
Paste this into your coding agent and it claims the listing for you. Valid, listed, verified profiles are eligible for search-engine visibility. Verified sites are listed by name in our llms-full.txt, the file agents read, and get a private dashboard for listing controls, file health, measured activity and score history.
Claim my listing on Agent Web Map for cancerworld.net:
1. POST https://agentwebmap.com/v1/sites/cancerworld.net/claims and keep claim_id and claim_secret private.
2. Publish the proof: add the line "AgentWebMap ownership: <token>" (token from step 1) to https://cancerworld.net/llms.txt, or use the DNS, meta-tag or well-known method the response describes.
3. POST https://agentwebmap.com/v1/sites/cancerworld.net/verify with {"claim_id": "...", "claim_secret": "..."}.
4. Save the api_key from the answer; it manages the listing (PATCH https://agentwebmap.com/v1/sites/cancerworld.net).
MCP equivalent: tools begin_ownership_claim, then verify_domain, at https://agentwebmap.com/mcp. Docs: https://agentwebmap.com/docs#verifyCorrections or removal requests: contact the directory. Ownership management is optional.
Cancerworld Magazine
Their llms.txt
The beginning of the file, from our validated copy saved 2026-10-20T19:52:51.685Z. Cached copy · Source on cancerworld.net
Generated by All in One SEO v4.9.6.2, this is an llms.txt file, used by LLMs to index the site.
# Cancerworld Magazine
## Sitemaps
- [XML Sitemap](https://cancerworld.net/sitemap.xml): Contains all public & indexable URLs for this website.
## Posts
- [Multi-cancer early detection blood test speeds up cancer diagnosis](https://cancerworld.net/multi-cancer-detection-blood-test/) - A multi-cancer early detection test showed a positive predictive accuracy of 75% and negative predictive accuracy of 98% in a population referred for diagnostic follow-up after presenting to primary care with symptoms of cancer. The SYMPLIFY study, abstract 1501, presented in an oral abstract session at the ASCO 2023 Annual Meeting, also found that the
- [Harald zur Hausen: the virologist who opened a pathway to eliminating cervical cancer](https://cancerworld.net/harald-zur-hausen/) - Harald zur Hausen, virologist and Nobel laureate, passed away on May 28th. His great discovery, that cervical cancer is caused by the human papilloma virus (HPV), opened the way for significantly reducing the risk of developing this disease – still the fourth biggest cancer killer of women globally – among upcoming generations the world over.
- [Cracking RAS: It took over 30 years to hit this ubiquitous oncogene – was it worth the wait?](https://cancerworld.net/cracking-ras-oncogene/) - RAS oncogenes and their proteins have central roles in almost all cancers, including leukaemias, multiple myelomas, skin cancers and many solid tumours, making the RAS protein family an ideal cancer target. But efforts to develop clinically efficacious drugs to target RAS, starting in the early 1990s, met with unforeseen hurdles and disappointing clinical progress. The
- [Stopping immunotherapy after two years does not affect NSCLC survival](https://cancerworld.net/stopping-immunotherapy-survival/) - No overall survival difference was found between patients with non-small cell lung cancer who stopped immune checkpoint inhibitors at two years and those continuing treatment indefinitely. The study, abstract 9101, presented at the ASCO 2023 Annual Meeting, held June 2–6, and published simultaneously online in JAMA Oncology, also showed that, after progression, patients treated with
- [Adding a CDK4/6 inhibitor to endocrine therapy improves outcomes in HR+ HER2– early-stage breast cancer](https://cancerworld.net/adding-a-cdk4-6-inhibitor-outcomes-breast-cancer/) - Adding the CDK4/6 inhibitor ribociclib to standard-of-care adjuvant endocrine therapy for treatment of hormone receptor-positive HER2-negative early-stage breast cancer reduced risk of recurrence by 25%. The phase III NATALEE study, abstract LBA500, presented at the ASCO 2023 Annual Meeting, held June 2–6, showed for the first time that ribociclib combined with endocrine therapy improved outcomes
- [Mariam Kukhalashvili: solving Georgia’s cancer problems](https://cancerworld.net/mariam-kukhalashvili-solving-georgias-cancer-problems/) - Clinical o
…
Related sites
Other listed sites in Media. See the whole category →
| Domain | Title | Category | Country | Authority | llms.txt | llms-full.txt |
|---|---|---|---|---|---|---|
| wordpress.org | WordPress | transactional Media Ecommerce | US | 77 | ✓ | |
| bilibili.com | Bilibili / 哔哩哔哩 | documentation Media | CN | 71 | ✓ | |
| weather.com | Weather.com | informational Media | FR | 71 | ✓ | |
| businessinsider.com | Business Insider | informational Media | 70 | ✓ | ||
| conviva.com | Conviva | transactional AI and machine learning Data and analytics +2 | US | 70 | ✓ | ✓ |
| foxnews.com | Fox News | documentation Media AI and machine learning | GB | 70 | ✓ | |
| opendemocracy.net | openDemocracy | documentation Media | NL | 70 | ✓ | ✓ |
| capcut.com | CapCut | documentation Media | FR | 69 | ✓ |
Help agents understand your site
Optionally manage your description, publish terms for agents, review file health, measured discovery requests, publisher clicks and score history. Confirm domain control in your browser using a fresh token in your llms.txt, DNS, meta tag or well-known file. No backlink is required.
Manage this listing → · Agent and API instructions
Machine-readable: GET /v1/resolve?q=cancerworld.net · GET /v1/domain/cancerworld.net · this page as Accept: application/json or text/markdown · MCP lookup_domain